Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Heart (British Cardiac Society)|November 23, 2007
External validation of established risk adjustment models for procedural complications after percutaneous coronary interventionB Kunadian, J Dunning, R Das, et al.Journal of Cardiovascular Pharmacology and Therapeutics|January 8, 2019
Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center ExperienceMatthew Jackson, Sarah Callaghan, John Stapleton, et al.Ebiomedicine|November 28, 2025
First-in-human high dose AAV9 intrathecal gene therapy for paediatric CLN7 disease: a phase 1, open-label, single ascending dose, non-randomised clinical trialBenjamin M Greenberg, Berge Minassian, Souad Messahel, et al.International Journal of Cardiology|May 3, 2016
The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary interventionZ Adam, A Turley, J M Mason, et al.American Heart Journal|April 25, 2007
Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trialBabu Kunadian, Andrew G C Sutton, Kunadian Vijayalakshmi, et al.Journal of the American College of Cardiology|July 21, 2004
A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trialAndrew G C Sutton, Philip G Campbell, Richard Graham, et al.Heart (British Cardiac Society)|September 16, 2005
One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trialA G C Sutton, P G Campbell, R Graham, et al.The American Journal of Gastroenterology|August 27, 2019
Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical PracticeJasmohan S Bajaj, Patricia Pringle Bloom, Raymond T Chung, et al.Plos One|December 1, 2022
Population-based correlates of COVID-19 infection: An analysis from the DFW COVID-19 prevalence studyAmit G Singal, Andrew Masica, Kate Esselink, et al.Iscience|January 10, 2022
SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energeticsKarthik Ramachandran, Soumya Maity, Alagar R Muthukumar, et al.Pageof 11